EyePoint Pharmaceuticals Inc
NASDAQ: EYPT
$8.95
+$0.60 (+7.2%)
Closing Price on November 22, 2024
EYPT Stock Chart and Intraday Price
EYPT Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Address | 480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US |
| Fiscal Year End | December |
| Latest Quarter | 9/30/2023 |
| Market Cap | 1,367.49M USD |
| Shares Outstanding | 48,838,800 |
EYPT Articles
A public offering of shares this past week prompted a huge purchase from a beneficial owner. Meanwhile, a couple of repeat buyers further boosted their stakes as well.
Published:
Even as the earnings-reporting season has begun to slow in the past week, some insiders and beneficial owners were adding to their stakes.
Published:
Initial public offerings and a secondary offering inspired insiders to pick up some shares of these biotech companies and others.
Published:
As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at these biotech companies.
Published:
As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.
Published:
Warren Buffett's Berkshire Hathaway has bolstered its stake in Occidental Petroleum with a huge purchase of shares. Insider buying is heating up in general.
Published:
A biotech stock rallying on encouraging trial results prompted insider buying and selling. A specialty retailer and others saw insider buying too.
Published: